Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys.

Hartman HA, Myers LA, Evans M, Robison RL, Engstrom RG, Tse FL.

Fundam Appl Toxicol. 1996 Jan;29(1):48-62.

PMID:
8838639
2.
3.

The toxicity of a fluorinated-biphenyl HMG-CoA reductase inhibitor in beagle dogs.

Gerson RJ, Allen HL, Lankas GR, MacDonald JS, Alberts AW, Bokelman DL.

Fundam Appl Toxicol. 1991 Feb;16(2):320-9.

PMID:
2055362
4.

Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae.

Tse FL, Dain JG, Kalafsky G.

Biopharm Drug Dispos. 1995 Apr;16(3):211-9.

PMID:
7787133
5.
6.

Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey.

Tse FL, Smith HT, Ballard FH, Nicoletti J.

Biopharm Drug Dispos. 1990 Aug-Sep;11(6):519-31.

PMID:
2207302
7.
8.
9.

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.

Plosker GL, Wagstaff AJ.

Drugs. 1996 Mar;51(3):433-59. Review.

PMID:
8882381
10.

Clinical implications of the biopharmaceutical properties of fluvastatin.

Deslypere JP.

Am J Cardiol. 1994 May 26;73(14):12D-17D.

PMID:
8198018
11.

Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.

Sasaki S, Nakagawa M, Nakata T, Endo N, Miyao K, Kitamura K, Fukuyama M, Kitani T, Yamada C.

Cardiology. 1997 Mar-Apr;88(2):160-5.

PMID:
9096917
13.
14.
15.

Atorvastatin is not cataractogenic in beagle dogs.

Robertson DG, Urda ER, Rothwell CE, Walsh KM.

Curr Eye Res. 1997 Dec;16(12):1229-35.

PMID:
9426956
16.
17.

Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor.

von Keutz E, Schlüter G.

Am J Cardiol. 1998 Aug 27;82(4B):11J-17J.

PMID:
9737641
18.
19.

Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.

Park JW, Siekmeier R, Lattke P, Merz M, Mix C, Schüler S, Jaross W.

J Cardiovasc Pharmacol Ther. 2001 Oct;6(4):351-61.

PMID:
11907637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk